Christopher M. Yea Ph.D.
Net Worth

Last updated:

What is Christopher M. Yea Ph.D. net worth?

The estimated net worth of Dr. Christopher M. Yea Ph.D. is at least $7,365,126 as of 26 Nov 2024. He owns shares worth $1,167,529 as insider, has earned $2,013,557 from insider trading and has received compensation worth at least $4,184,040 in KalVista Pharmaceuticals, Inc..

What is the salary of Christopher M. Yea Ph.D.?

Dr. Christopher M. Yea Ph.D. salary is $697,340 per year as Chief Devel. Officer in KalVista Pharmaceuticals, Inc..

How old is Christopher M. Yea Ph.D.?

Dr. Christopher M. Yea Ph.D. is 61 years old, born in 1964.

What stocks does Christopher M. Yea Ph.D. currently own?

As insider, Dr. Christopher M. Yea Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
KalVista Pharmaceuticals, Inc. (KALV) Chief Devel. Officer 91,142 $12.81 $1,167,529

What does KalVista Pharmaceuticals, Inc. do?

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed a Phase II clinical trial for the treatment of DME; sebetralstat, which is initiation of the Phase 3 KONFIDENT trial as a potential oral, on-demand therapy for HAE attacks; KVD824, an oral product candidate for the treatment of HAE; and Factor XIIa, an oral inhibitor program which is in preclinical stage targets an enzyme in HAE. The company is headquartered in Cambridge, Massachusetts.

KALV logo
KALV
KalVista Pharmaceuticals, Inc.
$12.81

Christopher M. Yea Ph.D. insider trading

KalVista Pharmaceuticals, Inc.

Dr. Christopher M. Yea Ph.D. has made 33 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently he sold 1,963 units of KALV stock worth $19,379 on 26 Nov 2024.

The largest trade he's ever made was exercising 39,886 units of KALV stock on 14 Feb 2024. As of 26 Nov 2024 he still owns at least 91,142 units of KALV stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 1,963 $9.87 $19,379
Option
Common Stock 3,125 N/A N/A
Option
Restricted Stock Unit 3,125 N/A N/A
Sale
Common Stock 7,192 $9.26 $66,576
Option
Restricted Stock Unit 1,774 N/A N/A
Option
Common Stock 11,496 N/A N/A
Option
Performance Stock Units 7,291 N/A N/A
Option
Restricted Stock Unit 2,431 N/A N/A
Sale
Common Stock 1,916 $12.4 $23,758
Option
Restricted Stock Unit 3,125 N/A N/A
Option
Common Stock 3,125 N/A N/A
Sale
Common Stock 7,102 $12.01 $85,316
Option
Common Stock 11,495 N/A N/A
Option
Performance Stock Units 7,292 N/A N/A
Option
Restricted Stock Unit 2,430 N/A N/A
Option
Restricted Stock Unit 1,773 N/A N/A
Sale
Common Stock 11,610 $11.77 $136,592
Option
Restricted Stock Unit 1,774 N/A N/A
Option
Performance Stock Units 7,292 N/A N/A
Option
Restricted Stock Unit 2,431 N/A N/A
Option
Common Stock 18,789 N/A N/A
Option
Performance Stock Units 7,292 N/A N/A
Sale
Common Stock 12,053 $14.12 $170,128
Option
Common Stock 18,788 N/A N/A
Option
Performance Stock Units 7,292 N/A N/A
Option
Performance Stock Units 7,292 N/A N/A
Option
Restricted Stock Unit 2,430 N/A N/A
Option
Restricted Stock Unit 1,774 N/A N/A
Sale
Common Stock 39,886 $15.01 $598,649
Sale
Common Stock 7,113 $8.23 $58,533
Option
Restricted Stock Unit 1,774 N/A N/A
Option
Restricted Stock Unit 2,431 N/A N/A
Option
Common Stock 11,497 N/A N/A
Option
Performance Stock Unit 7,292 N/A N/A
Sale
Common Stock 7,142 $10.73 $76,627
Option
Restricted Stock Unit 2,430 N/A N/A
Option
Restricted Stock Unit 1,773 N/A N/A
Option
Common Stock 11,494 N/A N/A
Option
Performance Stock Unit 7,291 N/A N/A
Sale
Common Stock 2,604 $10.14 $26,415
Option
Common Stock 4,205 N/A N/A
Option
Restricted Stock Unit 2,431 N/A N/A
Option
Restricted Stock Unit 1,774 N/A N/A
Option
Restricted Stock Unit 1,774 N/A N/A
Sale
Common Stock 2,727 $7.66 $20,889
Option
Performance Restricted Stock Unit 2,430 N/A N/A
Option
Common Stock 4,204 N/A N/A
Sale
Common Stock 1,139 $5.44 $6,196
Option
Common Stock 1,774 N/A N/A
Option
Restricted Stock Unit 1,774 N/A N/A
Sale
Common Stock 1,145 $14.96 $17,130
Option
Restricted Stock Unit 1,773 N/A N/A
Option
Common Stock 1,773 N/A N/A
Sale
Common Stock 5,000 $18.07 $90,330
Sale
Common Stock 5,000 $20.52 $102,580
Sale
Common Stock 5,000 $24.84 $124,195
Sale
Common Stock 15,000 N/A N/A
Sale
Common Stock 15,000 $8.85 $132,720
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 6,044 N/A N/A
Sale
Common Stock 6,044 $8.84 $53,441
Sale
Common Stock 7,942 N/A N/A
Sale
Common Stock 914 N/A N/A
Sale
Common Stock 100 N/A N/A
Sale
Common Stock 2,646 N/A N/A
Option
Employee Stock Option (Right to Buy) 2,646 N/A N/A
Option
Common Stock 2,646 N/A N/A
Option
Common Stock 3,010 N/A N/A
Sale
Common Stock 3,010 N/A N/A
Option
Employee Stock Option (Right to Buy) 3,010 N/A N/A
Option
Common Stock 1,500 N/A N/A
Sale
Common Stock 1,500 N/A N/A
Option
Employee Stock Option (Right to Buy) 1,500 N/A N/A
Option
Common Stock 199 N/A N/A
Option
Employee Stock Option (Right to Buy) 199 N/A N/A
Sale
Common Stock 199 N/A N/A
Option
Employee Stock Option (Right to Buy) 7,355 N/A N/A
Sale
Common Stock 7,355 $0 $29
Option
Common Stock 7,355 $0 $29
Option
Employee Stock Option (Right to Buy) 7,355 $0 $29
Sale
Common Stock 7,355 $26.36 $193,841
Option
Common Stock 7,355 $0 $29
Option
Common Stock 5,453 $0 $22
Option
Employee Stock Option (Right to Buy) 5,453 $0 $22
Sale
Common Stock 5,453 $0 $22
Option
Employee Stock Option (Right to Buy) 600 $17.01 $10,205
Sale
Common Stock 600 $17.01 $10,205
Option
Common Stock 600 $17.01 $10,205
Option
Common Stock 1,302 $0 $5
Option
Employee Stock Option (Right to Buy) 1,302 $0 $5
Sale
Common Stock 1,302 $0 $5

KalVista Pharmaceuticals key executives

KalVista Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: